These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22378737)

  • 1. Methods for iPS cell generation for basic research and clinical applications.
    Mochiduki Y; Okita K
    Biotechnol J; 2012 Jun; 7(6):789-97. PubMed ID: 22378737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective generation of iPS cells from CD34+ cord blood cells by inhibition of p53.
    Takenaka C; Nishishita N; Takada N; Jakt LM; Kawamata S
    Exp Hematol; 2010 Feb; 38(2):154-62. PubMed ID: 19922768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cells.
    Zaehres H; Kim JB; Schöler HR
    Methods Enzymol; 2010; 476():309-25. PubMed ID: 20691874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
    Cheng D; Lei L; Lu Z; Li Z; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem (iPS) cell research overview.
    Liu SP; Fu RH; Huang YC; Chen SY; Chien YJ; Hsu CY; Tsai CH; Shyu WC; Lin SZ
    Cell Transplant; 2011; 20(1):15-9. PubMed ID: 20887681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of pluripotency by defined factors.
    Okita K; Yamanaka S
    Exp Cell Res; 2010 Oct; 316(16):2565-70. PubMed ID: 20420827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of human-induced pluripotent stem cells.
    Park IH; Lerou PH; Zhao R; Huo H; Daley GQ
    Nat Protoc; 2008; 3(7):1180-6. PubMed ID: 18600223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
    Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
    Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
    Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of pig induced pluripotent stem cells with a drug-inducible system.
    Wu Z; Chen J; Ren J; Bao L; Liao J; Cui C; Rao L; Li H; Gu Y; Dai H; Zhu H; Teng X; Cheng L; Xiao L
    J Mol Cell Biol; 2009 Oct; 1(1):46-54. PubMed ID: 19502222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of induced pluripotent stem cells with CytoTune, a non-integrating Sendai virus.
    Lieu PT; Fontes A; Vemuri MC; Macarthur CC
    Methods Mol Biol; 2013; 997():45-56. PubMed ID: 23546747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolving field of induced pluripotency: recent progress and future challenges.
    Sommer CA; Mostoslavsky G
    J Cell Physiol; 2013 Feb; 228(2):267-75. PubMed ID: 22767332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human amniotic epithelial cell feeder layers maintain human iPS cell pluripotency via inhibited endogenous microRNA-145 and increased Sox2 expression.
    Liu T; Cheng W; Huang Y; Huang Q; Jiang L; Guo L
    Exp Cell Res; 2012 Feb; 318(4):424-34. PubMed ID: 22200372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved method for generating and identifying human induced pluripotent stem cells.
    Mali P; Ye Z; Chou BK; Yen J; Cheng L
    Methods Mol Biol; 2010; 636():191-205. PubMed ID: 20336524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pluripotency can be rapidly and efficiently induced in human amniotic fluid-derived cells.
    Li C; Zhou J; Shi G; Ma Y; Yang Y; Gu J; Yu H; Jin S; Wei Z; Chen F; Jin Y
    Hum Mol Genet; 2009 Nov; 18(22):4340-9. PubMed ID: 19679563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.
    Song M; Paul S; Lim H; Dayem AA; Cho SG
    Arch Pharm Res; 2012 Feb; 35(2):245-60. PubMed ID: 22370779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.
    López-González R; Velasco I
    Arch Med Res; 2012 Jan; 43(1):1-10. PubMed ID: 22293229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of reprogramming ability of mouse ES and iPS cells measured by somatic cell fusion.
    Sumer H; Nicholls C; Liu J; Tat PA; Liu JP; Verma PJ
    Int J Dev Biol; 2010; 54(11-12):1723-8. PubMed ID: 21404192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advance in study of induced pluripotent stem cells (iPS cells)].
    Aoi T
    Nihon Rinsho; 2008 May; 66(5):850-6. PubMed ID: 18464501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.